PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation

Hu, Juan ; Zhang, Jing‐Jing ; Li, Li ; Wang, Shan‐Ling ; Yang, Hai‐Tao ; Fan, Xian‐Wei ; Zhang, Lei‐Ming ; Hu, Guang‐Ling ; Fu, Hai‐Xia ; Song, Wei‐Feng ; Yan, Li‐Jie ; Liu, Jing‐Jing ; Wu, Jin‐Tao ; Kong, Bin

Journal of cellular and molecular medicine, 2021-07, Vol.25 (14), p.6746-6759 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível